PURE Bioscience (OTCMKTS:PURE) Shares Shorted: Short Interest Down 54.8% in October
by Mitch Edgeman · The Markets DailyPURE Bioscience (OTCMKTS:PURE – Get Free Report) was the target of a large drop in short interest in October. As of October 30th, there was short interest totaling 1,982 shares, a drop of 54.8% from the October 15th total of 4,381 shares. Currently, 0.0% of the shares of the stock are short sold. Based on an average trading volume of 26,909 shares, the short-interest ratio is currently 0.1 days.
PURE Bioscience Price Performance
OTCMKTS:PURE remained flat at $0.06 during mid-day trading on Tuesday. 38,070 shares of the company were exchanged, compared to its average volume of 21,423. PURE Bioscience has a fifty-two week low of $0.04 and a fifty-two week high of $0.10. The stock has a market capitalization of $7.80 million, a PE ratio of -3.00 and a beta of 0.34. The business has a 50 day simple moving average of $0.07 and a 200-day simple moving average of $0.07.
PURE Bioscience Company Profile
PURE Bioscience develops and commercializes antimicrobial products based on silver dihydrogen citrate (SDC), a proprietary formulation designed to control bacteria and other microorganisms. The company focuses on applications where surface hygiene and food safety are important. Its offerings include SDC-based disinfectant and sanitizer products for hard surfaces, including products intended for food-processing and food-service environments. PURE Bioscience also pursues commercial partnerships to market its technology and products.
See Also
- Five stocks we like better than PURE Bioscience
- Amazon’s Black Friday Rush Could Kick Off a Holiday Season That Defines Its Year
- The Next Nuclear Opportunity May Be in Fuel, Not Reactors: 3 Stocks to Watch
- Tyson Foods’ Earnings Beat Hides a Warning for Consumer Staples Dividend Investors
- 3 Stocks in an Overlooked Corner of Infrastructure With Hundreds of Billions at Stake